Veeva Systems (NYSE:VEEV – Free Report) had its target price boosted by Morgan Stanley from $195.00 to $201.00 in a report ...

Additionally, it provides analytics through Veeva Crossix, customer data via Veeva OpenData, and real-time intelligence with Veeva Link. The company also supports clinical, regulatory, and safety ...

At this time, I would like to welcome everyone to the Veeva Systems fiscal 2025 fourth quarter and full-year results ...

Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time ...

In this article, we are going to take a look at where Veeva Systems Inc. (NYSE:VEEV) stands against the other health information services stocks. Health Information Services stocks have become a ...

Veeva wholly supports this shift ... this last available from December 2024); Patient (Patient CRM); and Crossix (Consumer, HCP, Audiences) capabilities. Modular content is also cost-effective.

Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time ...